Increasing evidence links dysregulation of NMDA receptors trafficking to AD.14, 30, 31 Aβ oligomers disturb the function of GluN2B-containing NMDA receptors and associated signaling molecules and impair both glutamatergic transmission and synaptic plasticity. This evidence concerns the gene GRIN2B and Alzheimer disease.